IPSEFIpsen S.A.

About Ipsen S.A. (IPSEF)

Ipsen S.A. (IPSEF) is a Drug Manufacturers - Specialty & Generic company headquartered in Boulogne-Billancourt, France whose shares trade over-the-counter on the Pink tier.

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding 1.2 billion in 2012. Ipsen's ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by four franchises: neurology, endocrinology and uro-oncology. Moreover, the Group has an active policy of partnerships. R&D is focused on innovative and differentiated technological patient-driven platforms, peptides and toxins. In 2012, R&D expenditure totaled close to 250 million, representing more than 20% of Group sales. The Group has total worldwide staff of close to 4,900 employees.

IPSEF key facts

Ticker symbol

IPSEF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Boulogne-Billancourt, France

Country of incorporation

FR

Estimated market cap

$8.55B (as of Apr 16, 2025)

Shares outstanding

82,647,356

Reporting standard

International Reporting: Euronext Paris

Audit status

Audited

Fiscal year end

12/31

Ipsen S.A. leadership

• Jean-Luc Belingard — CEO
• Caire Giraut — EVP, CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with I